These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9927744)

  • 1. Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells.
    Pan W; Ravot E; Tolle R; Frank R; Mosbach R; Türbachova I; Bujard H
    Nucleic Acids Res; 1999 Feb; 27(4):1094-103. PubMed ID: 9927744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of an immunologically reactive merozoite surface protein (MSP-1(42)) in E. coli.
    Leung WH; Meng ZQ; Hui G; Ho WK
    Biochim Biophys Acta; 2004 Nov; 1675(1-3):62-70. PubMed ID: 15535968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum.
    Uthaipibull C; Aufiero B; Syed SE; Hansen B; Guevara Patiño JA; Angov E; Ling IT; Fegeding K; Morgan WD; Ockenhouse C; Birdsall B; Feeney J; Lyon JA; Holder AA
    J Mol Biol; 2001 Apr; 307(5):1381-94. PubMed ID: 11292349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine.
    Angov E; Aufiero BM; Turgeon AM; Van Handenhove M; Ockenhouse CF; Kester KE; Walsh DS; McBride JS; Dubois MC; Cohen J; Haynes JD; Eckels KH; Heppner DG; Ballou WR; Diggs CL; Lyon JA
    Mol Biochem Parasitol; 2003 May; 128(2):195-204. PubMed ID: 12742586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum.
    Woehlbier U; Epp C; Kauth CW; Lutz R; Long CA; Coulibaly B; Kouyaté B; Arevalo-Herrera M; Herrera S; Bujard H
    Infect Immun; 2006 Feb; 74(2):1313-22. PubMed ID: 16428781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic properties of a recombinant fusion protein containing the C-terminal 19 kDa of Plasmodium falciparum merozoite surface protein-1 and the innate immunity agonist FliC flagellin of Salmonella typhimurium.
    Bargieri DY; Leite JA; Lopes SC; Sbrogio-Almeida ME; Braga CJ; Ferreira LC; Soares IS; Costa FT; Rodrigues MM
    Vaccine; 2010 Apr; 28(16):2818-26. PubMed ID: 20170765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24.
    Gupta PK; Mukherjee P; Dhawan S; Pandey AK; Mazumdar S; Gaur D; Jain SK; Chauhan VS
    Clin Vaccine Immunol; 2014 Jun; 21(6):886-97. PubMed ID: 24789797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
    Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium falciparum 19 kDa of merozoite surface protein-1 (MSP-1(19)) expressed in Mycobacterium bovis bacille Calmette Guerin (BCG) is reactive with an inhibitory but not a blocking monoclonal antibody.
    Nurul AA; Rapeah S; Norazmi MN
    Trop Biomed; 2010 Apr; 27(1):60-7. PubMed ID: 20562815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and in vitro protective efficacy of recombinant Mycobacterium bovis bacille Calmette Guerin (rBCG) expressing the 19 kDa merozoite surface protein-1 (MSP-1(19)) antigen of Plasmodium falciparum.
    Nurul AA; Norazmi MN
    Parasitol Res; 2011 Apr; 108(4):887-97. PubMed ID: 21057812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium falciparum merozoite surface protein 1 (MSP-1)-MSP-3 chimeric protein: immunogenicity determined with human-compatible adjuvants and induction of protective immune response.
    Mazumdar S; Mukherjee P; Yazdani SS; Jain SK; Mohmmed A; Chauhan VS
    Infect Immun; 2010 Feb; 78(2):872-83. PubMed ID: 19933832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of a recombinant malaria candidate vaccine in Escherichia coli by codon optimization.
    Zhou Z; Schnake P; Xiao L; Lal AA
    Protein Expr Purif; 2004 Mar; 34(1):87-94. PubMed ID: 14766303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.
    Woehlbier U; Epp C; Hackett F; Blackman MJ; Bujard H
    Malar J; 2010 Mar; 9():77. PubMed ID: 20298576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa.
    John CC; O'Donnell RA; Sumba PO; Moormann AM; de Koning-Ward TF; King CL; Kazura JW; Crabb BS
    J Immunol; 2004 Jul; 173(1):666-72. PubMed ID: 15210830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system.
    Pang AL; Hashimoto CN; Tam LQ; Meng ZQ; Hui GS; Ho WK
    Infect Immun; 2002 Jun; 70(6):2772-9. PubMed ID: 12010962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and purification of Plasmodium falciparum MSP-1(42): A malaria vaccine candidate.
    Epp C; Kauth CW; Bujard H; Lutz R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Mar; 786(1-2):61-72. PubMed ID: 12651002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merozoite surface protein-1 epitopes recognized by antibodies that inhibit Plasmodium falciparum merozoite dispersal.
    Lyon JA; Carter JM; Thomas AW; Chulay JD
    Mol Biochem Parasitol; 1997 Dec; 90(1):223-34. PubMed ID: 9497045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A malaria vaccine based on the polymorphic block 2 region of MSP-1 that elicits a broad serotype-spanning immune response.
    Cowan GJ; Creasey AM; Dhanasarnsombut K; Thomas AW; Remarque EJ; Cavanagh DR
    PLoS One; 2011; 6(10):e26616. PubMed ID: 22073118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.
    O'Donnell RA; de Koning-Ward TF; Burt RA; Bockarie M; Reeder JC; Cowman AF; Crabb BS
    J Exp Med; 2001 Jun; 193(12):1403-12. PubMed ID: 11413195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.